Valuation Genmab A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 09:50:00 13/02/2026 pm IST			5-day change	1st Jan Change
1,904.50 ^DKK	+1.25%		-2.73%	-6.04%

13/02	Diary - Europe's STOXX 600 Corporate Earnings Week Ahead	RE
21/01	DNB Carnegie Upgrades Genmab to Buy, Raises PT	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	1,61,105	1,72,063	1,92,229	1,40,770	94,810	1,17,316	1,17,316	-
Change	-	6.8%	11.72%	-26.77%	-32.65%	23.74%	0%	-
Enterprise Value (EV) ¹	1,45,026	1,52,725	1,69,905	1,12,635	73,709	89,397	86,718	80,264
Change	-	5.31%	11.25%	-33.71%	-34.56%	21.28%	-3%	-7.44%
P/E ratio	34.1x	57.8x	35.2x	32.6x	12.3x	16.2x	18.4x	14x
PBR	8.5x	7.82x	7.07x	4.5x	2.68x	3.1x	2.68x	2.29x
PEG	-	-1.6x	0.4x	-1.5x	0.1x	-5.68x	-1.5x	0.4x
Capitalization / Revenue	15.9x	20.3x	13.2x	8.54x	4.4x	4.94x	4.27x	3.65x
EV / Revenue	14.3x	18x	11.6x	6.84x	3.42x	3.76x	3.15x	2.5x
EV / EBITDA	22.1x	46.8x	25.3x	20.1x	10.4x	9.95x	9.03x	6.34x
EV / EBIT	23x	50.6x	26.7x	21.2x	10.5x	10.5x	10x	7.11x
EV / FCF	23.7x	77.3x	47.3x	16.1x	9.72x	14.5x	9.78x	7.3x
FCF Yield	4.22%	1.29%	2.12%	6.23%	10.3%	6.89%	10.2%	13.7%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	72.21	45.54	83.65	66.02	121.4	117.9	103.5	136
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	10,111	8,482	14,595	16,474	21,526	23,750	27,491	32,138
EBITDA ¹	6,572	3,266	6,719	5,616	7,116	8,988	9,607	12,656
EBIT ¹	6,313	3,018	6,357	5,321	7,003	8,498	8,650	11,293
Net income ¹	4,758	3,008	5,522	4,352	7,844	7,526	6,999	10,524
Net Debt ¹	-16,079	-19,338	-22,324	-28,135	-21,101	-27,919	-30,598	-37,052
Reference price ²	2,463.00	2,630.00	2,941.00	2,155.00	1,492.50	1,904.50	1,904.50	1,904.50
Nbr of stocks (in thousands)	65,410	65,423	65,362	65,322	63,524	61,599	61,599	-
Announcement Date	23/02/21	16/02/22	22/02/23	14/02/24	12/02/25	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GENMAB A/S	16.15x	3.76x	9.95x	-.--%	1.86TCr
ARGENX SE	47.83x	11.28x	40.69x	0.02%	5.15TCr
WUXI APPTEC CO., LTD.	17.58x	6.38x	14.04x	1.7%	4.43TCr
INSMED INCORPORATED	-25.5x	51.38x	-29.37x	-.--%	3.17TCr
BIONTECH SE	-26.07x	4.34x	-11.95x	-.--%	2.66TCr
WUXI BIOLOGICS (CAYMAN) INC.	29.5x	6.39x	17.71x	-.--%	2.12TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-173.33x	42.7x	-172.64x	-.--%	1.25TCr
AKESO, INC.	-318.07x	25.02x	1052.59x	-.--%	1.24TCr
SUMMIT THERAPEUTICS INC.	-11.33x	141.5x	-22.06x	-.--%	1.15TCr
EXELIXIS, INC.	14.35x	4.02x	9.51x	-.--%	1.14TCr
Average	-42.89x	29.68x	90.85x	0.17%	2.42TCr
Weighted average by Cap.	-14.12x	22.08x	52.90x	0.32%